Short-term effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve: A pilot randomized controlled trial

Fertility and Sterility

Volumn 100, Issue 6, 2013, Pages 1704-1708

  Findley, Austin D ^a   Siedhoff, Matthew T ^a   Hobbs, Kumari A ^a   Steege, John F ^a   Carey, Erin T ^a   McCall, Christina A ^a   Steiner, Anne Z ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Antim llerian hormone; hysterectomy; ovarian reserve; salpingectomy

Indexed keywords

MUELLERIAN INHIBITING FACTOR;

ADULT; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HUMAN; HYSTERECTOMY; LAPAROSCOPIC SURGERY; MEDICAL RECORD; OPERATION DURATION; OUTCOME ASSESSMENT; OVARIAN PRESERVATION; OVARIAN RESERVE; PILOT STUDY; POSTOPERATIVE PERIOD; PREMENOPAUSE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SALPINGECTOMY; TERTIARY HEALTH CARE; ADOLESCENT; EARLY MENOPAUSE; INFERTILITY, FEMALE; LAPAROSCOPY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OVARIAN NEOPLASMS; OVULATION; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYSTERECTOMY; INFERTILITY, FEMALE; LAPAROSCOPY; MENOPAUSE, PREMATURE; MIDDLE AGED; OVARIAN NEOPLASMS; OVULATION; PILOT PROJECTS; PREMENOPAUSE; SALPINGECTOMY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84888434522     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2013.07.1997     Document Type: Article

References (22)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. D.D. Bowtell The genesis and evolution of high-grade serous ovarian cancer Nat Rev Cancer 10 2010 803 808
3. R.J. Kurman, and M. Shih Ie Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer - shifting the paradigm Hum Pathol 42 2011 918 931
4. D.A. Levine, P.A. Argenta, C.J. Yee, D.S. Marshall, N. Olvera, and F. Bogomolniy Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations J Clin Oncol 21 2003 4222 4227
5. A.A. Tone, S. Salvador, S.J. Finlayson, A.V. Tinker, J.S. Kwon, and C.H. Lee The role of the fallopian tube in ovarian cancer Clin Adv Hematol Oncol 10 2012 296 306
6. C.K. Anderson, S. Wallace, M. Guiahi, J. Sheeder, K. Behbakht, and M.A. Spillman Risk-reducing salpingectomy as preventative strategy for pelvic serous cancer Int J Gynecol Cancer 23 2013 417 421
7. A. Asante, M.K. Whiteman, A. Kulkarni, S. Cox, P.A. Marchbanks, and D.J. Jamieson Elective oophorectomy in the United States: trends and in-hospital complications, 1998-2006 Obstet Gynecol 116 2010 1088 1095
8. J.M. Wu, M.E. Wechter, E.J. Geller, T.V. Nguyen, and A.G. Visco Hysterectomy rates in the United States, 2003 Obstet Gynecol 110 2007 1091 1095
9. K.F. Schulz, D.G. Altman, and D. Moher CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials Obstet Gynecol 115 2010 1063 1070
10. H.J. Chang, S.H. Han, J.R. Lee, B.C. Jee, B.I. Lee, and C.S. Suh Impact of laparoscopic cystectomy on ovarian reserve: serial changes of serum anti-Müllerian hormone levels Fertil Steril 94 2010 343 349
11. M. Sezik, O. Ozkaya, F. Demir, H.T. Sezik, and H. Kaya Total salpingectomy during abdominal hysterectomy: effects on ovarian reserve and ovarian stromal blood flow J Obstet Gynaecol Res 33 2007 863 869
12. M. Morelli, R. Venturella, R. Mocciaro, A. Di Cello, E. Rania, and D. Lico Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere Gynecol Oncol 129 2013 448 451
13. B. Almog, I. Wagman, G. Bibi, Y. Raz, F. Azem, and A. Groutz Effects of salpingectomy on ovarian response in controlled ovarian hyperstimulation for in vitro fertilization: a reappraisal Fertil Steril 95 2011 2474 2476
14. A. de Vet, J.S. Laven, F.H. de Jong, A.P. Themmen, and B.C. Fauser Antimüllerian hormone serum levels: a putative marker for ovarian aging Fertil Steril 77 2002 357 362
15. A. Hazout, P. Bouchard, D.B. Seifer, P. Aussage, A.M. Junca, and P. Cohen-Bacrie Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol Fertil Steril 82 2004 1323 1329
16. F.R. Tehrani, N. Shakeri, M. Solaymani-Dodaran, and F. Azizi Predicting age at menopause from serum antimüllerian hormone concentration Menopause 18 2011 766 770
17. F.R. Tehrani, M. Solaymani-Dodaran, and F. Azizi A single test of antimüllerian hormone in late reproductive-aged women is a good predictor of menopause Menopause 16 2009 797 802
18. F.R. Tehrani, M. Solaymani-Dodaran, M. Tohidi, M.R. Gohari, and F. Azizi Modeling age at menopause using serum concentration of anti-müllerian hormone J Clin Endocrinol Metab 98 2013 729 735
19. C.M. Shaw, F.Z. Stanczyk, B.L. Egleston, L.L. Kahle, C.S. Spittle, and A.K. Godwin Serum antimüllerian hormone in healthy premenopausal women Fertil Steril 95 2011 2718 2721
20. J.D. Wright, C.V. Ananth, S.N. Lewin, W.M. Burke, Y.S. Lu, and A.I. Neugut Robotically assisted vs laparoscopic hysterectomy among women with benign gynecologic disease JAMA 309 2013 689 698
21. A. Finch, M. Beiner, J. Lubinski, H.T. Lynch, P. Moller, and B. Rosen Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation JAMA 296 2006 185 192
22. J. Dietl, J. Wischhusen, and S.F. Hausler The post-reproductive fallopian tube: better removed? Hum Reprod 26 2011 2918 2924